Skip to main content

Arzneimittelinduzierte Leberschäden

  • Chapter
Praxis der Hepatologie

Zusammenfassung

Arzneimittelinduzierte Leberschäden („drug-induced liver injury“, DILI) bezeichnen alle durch Medikamente verursachten Schädigungen der Leber. Es schließt sowohl frei verkäufliche als auch rezeptpflichtige Medikamente ein. Die Leberschädigung kann hoch akut oder mit zeitlichem Abstand von einigen Wochen nach Einnahme eintreten. Die Schädigungen können von leichter und reversibler bis tödlicher Ausprägung sein. Da das Erkennen einer arzneimittelinduzierten Leberschädigung aufgrund des unspezifischen Beschwerdebildes und der zeitlichen Latenz sehr schwierig ist, ist ein hohes Maß an klinischer Aufmerksamkeit zur Diagnosestellung erforderlich.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 79.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 99.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  • Andrade RJ et al (2005) Drug-induced liver injury: an analysis of 461 incidences submitted to the Spanish registry over a 10-year period. Gastroenterology 129 (2):512–521

    Article  PubMed  Google Scholar 

  • Bénichou C (1990) Criteria of drug-induced liver disorders. Report of an international consensus meeting. J Hepatol 11(2):272–276

    Article  PubMed  Google Scholar 

  • Danan G, Benichou C (1993) Causality assessment of adverse reactions to drugs I. A novel method based on the conclusions of international consensus meetings: application to drug-induced liver injuries. J Clin Epidemiol 46:1323–1330

    Article  PubMed  CAS  Google Scholar 

  • Froomes PR et al (1999) Comparative effects of oxygen supplementation on theophylline and acetaminophen clearance in human cirrhosis. Gastroenterology 116(4):915–920

    Article  PubMed  CAS  Google Scholar 

  • Hadem J et al (2012) Etiologies and outcomes of acute liver failure in Germany. Clin Gastroenterol Hepatol Off Clin Pract J Am Gastroenterol Assoc 10(6):664–669

    Google Scholar 

  • HepNet (2012) No Title. HepNet J, (Ausgabe 2, 6. Jahrgang), 14

    Google Scholar 

  • Kaplowitz N (2005) Idiosyncratic drug hepatotoxicity. Nature reviews. Drug Discov 4(6):489–499

    Article  CAS  Google Scholar 

  • Larrey D (2002) Epidemiology and individual susceptibility to adverse drug reactions affecting the liver. Semin Liver Dis 22(2):145–155

    Article  PubMed  CAS  Google Scholar 

  • Lee WM (2003a) Acute liver failure in the United States. Semin Liver Dis 23(3):217–226

    Article  PubMed  CAS  Google Scholar 

  • Lee WM (2003b) Drug-induced hepatotoxicity – NEJM. N Engl J Med 349:474–485

    Article  PubMed  CAS  Google Scholar 

  • Lee WM et al (2009) Intravenous N-acetylcysteine improves transplant-free survival in early stage non-acetaminophen acute liver failure. Gastroenterology 137(3):856–864, 864.e1

    Article  PubMed  CAS  PubMed Central  Google Scholar 

  • Murray-Lyon IM et al (1976) Prognostic value of serum alpha-fetoprotein in fulminant hepatic failure including patients treated by charcoal haemoperfusion. Gut 17(8):576–580

    Article  PubMed  CAS  PubMed Central  Google Scholar 

  • Ostapowicz G et al (2002) Results of a prospective study of acute liver failure at 17 Tertiary Care Centers in the United States. Ann Intern Med 137(12):947–954

    Article  PubMed  Google Scholar 

  • Sgro C et al (2002) Incidence of drug-induced hepatic injuries: a French population-based study. Hepatology (Baltimore, Md) 36(2):451–455

    Article  Google Scholar 

  • Shapiro MA, Lewis JH (2007) Causality assessment of drug-induced hepatotoxicity: promises and pitfalls. Clin Liver Dis 11(3):477–505

    Article  PubMed  Google Scholar 

  • Smilkstein MJ et al (1988) Efficacy of oral Nacetylcysteine in the treatment of acetaminophen overdose. Analysis of the national multicenter study (1976 to 1985). N Engl J Med 319(24):1557–1562

    Article  PubMed  CAS  Google Scholar 

  • Staedt U et al (1993) Effects of ornithine aspartate on plasma ammonia and plasma amino acids in patients with cirrhosis. A double-blind, randomized study using a four-fold crossover design. J Hepatol 19(3):424–430

    Article  PubMed  CAS  Google Scholar 

  • Stirnimann G, Kessebohm K (2010) Liver injury caused by drugs: an update. Swiss Med Wkly 140:w13080

    Google Scholar 

  • Teschke R (2002) Liver damage caused by drugs. Deutsche medizinische Wochenschrift (1946) 127 (38):1953–1957

    Article  CAS  Google Scholar 

  • Thummel KE et al (2000) Ethanol and production of the hepatotoxic metabolite of acetaminophen in healthy adults. Clin Pharmacol Ther 67(6):591–599

    Article  PubMed  CAS  Google Scholar 

  • Watkins PB, Seeff LB (2006) Drug-induced liver injury: summary of a single topic clinical research conference. Hepatology 43(3):618–631

    Article  PubMed  Google Scholar 

  • Whitehead MW, Hainsworth I, Kingham JG (2001) The causes of obvious jaundice in South West Wales: perceptions versus reality. Gut 48(3):409–413

    Article  PubMed  CAS  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Christoph Höner zu Siederdissen .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2016 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

zu Siederdissen, C., Cornberg, M. (2016). Arzneimittelinduzierte Leberschäden. In: Manns, M., Schneidewind, S. (eds) Praxis der Hepatologie. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-41620-0_18

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-41620-0_18

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-41619-4

  • Online ISBN: 978-3-642-41620-0

  • eBook Packages: Medicine (German Language)

Publish with us

Policies and ethics